28 items
2026-09-12
Trial Holdings Inc. reported preliminary sales results for the month ended August 2026. For the month, the company reported comp. stores sales of 103.5% year-over-year. All store sales were 108.6% year-over-year.
2026-09-01
Unicorn GK entered into a share transfer agreement to acquire Seiyu Co., Ltd. from TRIAL Holdings, Inc. (TSE:141A) on August 21, 2026. The transaction is part of a multi-step corporate restructuring. Prior to the sale, Seiyu's retail operations will be internally transferred to another group subsidiary, ST Retail, Inc., leaving Seiyu Co., Ltd. as a holding company for a portfolio of real estate assets. This real estate holding entity is the subject of the sale. The transaction is structured as a sale-leaseback, allowing the retail stores to continue operations under a lease agreement. The divestiture is intended to monetize the real estate assets, with the seller aiming to raise approximately ¥17.0 billion to optimize its financial position. The expected completion of the transaction is December 1, 2026.
2026-08-26
TRIAL Holdings, Inc. provided consolidated earnings guidance for the six months ending December 31, 2026 and full fiscal year ending June 30, 2027. For the six months, the company expects net sales of JPY 733,100 million, operating profit of JPY 20,400 million, profit attributable to owners of parent of JPY 6,300 million and Basic earnings per share of JPY 51.31. For the full year, the company expects net sales of JPY 1,458,200 million, operating profit of JPY 39,000 million, profit attributable to owners of parent of JPY 10,700 million and Basic earnings per share of JPY 87.15.
2026-08-26
TRIAL Holdings, Inc. provided dividend guidance for the fiscal year ending June 30, 2027. For the year, the company expects to pay dividend of JPY 17.00 per share against JPY 17.00 per share a year ago.
2026-08-21
TRIAL Holdings, Inc., Board Meeting, Aug 21, 2026. Agenda: To consider Concerning an Absorption-type Company Split Between Subsidiaries (Sub-subsidiaries), Change of Company Names of Subsidiaries (Sub-subsidiaries), and Transfer of Shares Accompanying the Change in a Subsidiary (Sub-subsidiary) Associated with Partial Liquidation of Real Estate Held by Seiyu Co., Ltd.
2026-08-15
Trial Holdings Inc. reported preliminary sales results for the month ended July 2026. For the month, the company reported TRIAL’s all store sales of 110.6% year-over-year and SEIYU’s all store sales of 107.4% year-over-year.
2026-08-13
TRIAL Holdings, Inc., Annual General Meeting, Sep 25, 2026.
2026-08-13
TRIAL Holdings, Inc., Board Meeting, Aug 13, 2026. Agenda: To consider Regarding Differences Between Full-Year Consolidated Financial Results Forecast and Actual Results, and Dividends of Surplus (Dividend Increase).
2026-07-10
Trial Holdings Inc. reported preliminary sales results for the month, second half and full year ended June 2026. For the month, the company reported comp. stores sales of 101.6% year-over-year. All stores sales was 108.5% year-over-year. For the second half, the company reported comp. stores sales of 103.3% year-over-year. All stores sales was 110.5% year-over-year. For the full year, the company reported comp. stores sales of 102.1% year-over-year. All stores sales was 110.3% year-over-year.
2026-06-23
TRIAL Holdings, Inc. (the “Company”) hereby announces that the Company has resolved to execute a syndicated term loan agreement (the “Agreement”), with MUFG Bank Ltd. acting as arranger, for the purpose of refinancing its existing borrowings (the “Existing Borrowings”) (the “Refinancing”), as described below. The Company acquired all shares of Seiyu Co. Ltd. on July 1, 2025, and entered into a loan agreement with MUFG Bank Ltd. to finance the acquisition. The Refinancing is being undertaken because the Existing Borrowings were structured as a one-year bridge loan maturing on July 1, 2026. The overview of the syndicated loan is as follows: Contract execution date is June 26, 2026 (Scheduled). Loan amount is JPY 317.4 billion for Term Loan (1) and JPY 50 billion for Term Loan (2). Interest rate is JBA Japanese Yen TIBOR (3 months) + Spread. Scheduled drawdown date is July 1, 2026 (Scheduled). Loan period is 10 years. Repayment method is equal quarterly principal repayments commencing in September 2026. Collateral is unsecured. Arranger is MUFG Bank Ltd. Co-Arranger is Mizuho Bank Ltd. Agent is MUFG Bank Ltd. Lenders are domestic financial institutions. Interest payment method is payable in arrears on the last day of March, June, September, and December of each year. The following financial covenants are attached to the Loan Agreement. In the event of a breach of these covenants, the Company will forfeit the benefit of time and the borrowings may become immediately due and payable: As stated in the consolidated balance sheet as of the end of each fiscal period, the total amount of net assets must be maintained at no less than 75% of the total amount of net assets as of the end of the previous fiscal period. As stated in the consolidated statement of income for each fiscal period, no operating loss must be recorded for two consecutive fiscal periods. For Fiscal Year 2026 (July 1, 2025 to June 30, 2026), the Company expects to record approximately JPY 5,511 million of financing arrangement fees associated with the Refinancing as borrowing-related expenses within non-operating expenses. The impact of the Refinancing has already been incorporated into the Company's earnings forecast for the fiscal year ending June 30, 2026, announced on May 14, 2026, and there is no change to the earnings forecast. The interest rate applicable to the borrowings under the Agreement is within the range assumed when the Medium-Term Management Plan was formulated and announced on February 12, 2026. At present, there is no impact on the Company's earnings forecast for the fiscal year ending June 30, 2026 or on the Medium-Term Management Plan. Furthermore, the Company plans to fix the interest rate on a portion of the borrowings through a separate interest rate swap transaction to hedge against future interest rate fluctuations and secure borrowing costs. Should any matters requiring disclosure arise in the future, the Company will promptly disclose them.
2026-06-13
TRIAL Holdings, Inc. reported earnings results for the nine months ended March 31, 2026. For the nine months, the company reported sales was JPY 1,003,663 million compared to JPY 600,037 million a year ago. Net income was JPY 5,922 million compared to JPY 8,374 million a year ago. Basic earnings per share from continuing operations was JPY 48.39 compared to JPY 68.61 a year ago. Diluted earnings per share from continuing operations was JPY 48.05 compared to JPY 68.08 a year ago.
2026-06-10
TRIAL Holdings, Inc. announced that they will report fiscal year 2026 results on Aug 13, 2026
2026-05-27
TRIAL Holdings, Inc. revised earnings guidance for the fiscal year ending June 30, 2026. For the year ending June 30, 2026, the company expects net sales of JPY 1,342,500 million, operating profit of JPY 28,000 million, profit attributable to owners of parent of JPY 500 million and basic earnings per share of JPY 4.09 compared to previous guidance of net sales of JPY 1,322,500 million, operating profit of JPY 25,400 million, profit attributable to owners of parent of JPY 500 million and basic earnings per share of JPY 4.09. For the fiscal year ending June 30, 2026 (July 1, 2025 - June 30, 2026), net sales have been trending above the initial expectations. In addition to the continuous efforts to control selling, general and administrative (SG&A) expenses, non-operating expenses are expected to be lower than initially anticipated. As a result, net sales, operating profit, and ordinary profit are all expected to exceed the original forecasts. On the other hand, profit attributable to owners of parent remains unchanged, as company have factored in a certain amount of extraordinary losses.
2026-05-19
Trial Holdings Inc. reported preliminary sales results for the month and year to date Ended April 2026. For the month, the company reported comp. stores sales of 102.8% year-over-year. All store sales was 110.0% year-over-year. For the year-to-date, the company reported comp. stores sales of 101.7% and all stores sales of 109.9%.
2026-05-15
TRIAL Holdings, Inc. expected to report Fiscal Year 2026 results on August 13, 2026. This event was calculated by S&P Global (Created on May 15, 2026).
2026-05-09
TRIAL Holdings, Inc. announced that they will report Q3, 2026 results on May 14, 2026
2026-04-15
Trial Holdings Inc. reported preliminary sales results for the month and year to date ended March 2026. For the month, the company reported comp. stores sales of 100.3%. and all stores sales of 107.1%. For the year-to-date, the company reported comp. stores sales of 101.5% and all stores sales of 109.9%.
2026-03-16
Trial Holdings Inc. reported preliminary sales results for the month and year to date ended February 2026. For the month, the company reported comp. stores sales of 102.1% year-over-year. All store sales were 109.3% year-over-year. For the year to date, the company reported comp. stores sales of 101.7% year-over-year. All stores sales were 110.3% year-over-year.
2026-02-17
TRIAL Holdings, Inc., Q3 2026 Earnings Call, May 14, 2026
2026-02-16
Trial Holdings Inc. reported preliminary sales results for the month and year to date ended January 2026. For the month, the company reported comp. stores sales of 105.6% year-over-year. All store sales were 113.4% year-over-year. For the year to date, the company reported comp. stores sales of 101.6% year-over-year. All stores sales were 110.5% year-over-year.
2026-02-13
TRIAL Holdings, Inc. expected to report Q3 2026 results on May 14, 2026. This event was calculated by S&P Global (Created on February 13, 2026).
2026-01-12
Trial Holdings Inc. reported preliminary sales results for the month and year to date ended November 2025. For the month, the company reported comp. stores sales of 105.5% year-over-year. All store sales were 113.7% year-over-year. For the year to date, the company reported comp. stores sales of 101.3% year-over-year. All stores sales were 110.5% year-over-year.
2026-01-09
Trial Holdings Inc. reported preliminary sales results for the month and year to date ended December 2025. For the month, the company reported comp. stores sales of 99.8% year-over-year. All store sales were 102.3% year-over-year. For the year to date, the company reported comp. stores sales of 101.0% year-over-year. All stores sales were 110.0% year-over-year.
2025-12-11
TRIAL Holdings, Inc. announced that they will report Q2, 2026 results on Feb 12, 2026
2025-11-22
TRIAL Holdings, Inc., Q2 2026 Earnings Call, Feb 13, 2026
2025-11-21
Trial Holdings Inc. provided consolidated earnings guidance for the six months ending December 31, 2025 and year ending June 30, 2026. For the six months ending December 31, 2025, the company expects net sales of JPY 664,200 million, operating profit of JPY 10,400 million, profit attributable to owners of parent of JPY 800 million and basic earnings per share of JPY 6.54. For the year ending June 30, 2026, the company expects net sales of JPY 1,322,500 million, operating profit of JPY 25,400 million, profit attributable to owners of parent of JPY 500 million and basic earnings per share of JPY 4.09.
2025-11-21
TRIAL Holdings, Inc. provided year-end dividend guidance of JPY 16.00 per share for the fiscal year ending June 30, 2026 against JPY 16.00 per share a year ago.
2025-11-17
TRIAL Holdings, Inc. reported sales results for the month of October 2025. For the month, the company announced Comp. Stores sales of 101.7% and all stores sales of 110.1%.
2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 1,364,199 | 1,207,455 | 1,084,028 | 934,612 | 806,590 | 783,261 | 760,971 | 733,994 | 717,948 | 698,094 | 682,554 |
Pretax Income Excl.Unusual Items | 20,067 | 27,665 | 25,857 | 19,997 | 22,238 | 18,179 | 18,963 | 19,483 | 20,218 | 19,565 | 18,729 |
Total Assets | 807,824 | 784,941 | 850,466 | 752,494 | 300,283 | 271,070 | 314,627 | 255,301 | 283,627 | 275,377 | 251,259 |
Total Liabilities | 673,456 | 650,781 | 718,745 | 626,149 | 171,256 | 145,571 | 191,922 | 135,969 | 165,444 | 164,956 | 177,419 |
Cash & Cash Equivalents | 68,901 | 60,473 | 116,403 | 44,722 | 72,325 | 47,559 | 97,696 | 59,463 | 91,947 | 85,117 | 63,835 |
Total Common Equity | 130,902 | 130,868 | 128,548 | 123,398 | 126,124 | 122,672 | 119,966 | 116,773 | 115,680 | 108,001 | 71,492 |
Book Value Per Share (BVPS) | 1,066.22 | 1,067.07 | 1,050.3 | 1,008.91 | 1,031.28 | 1,003.19 | 982.64 | 957.57 | 1,110 | 911.25 | 734.61 |
Net Change in Cash | -3,424 | 18,708 | -19,621 | 33,859 | 68,048 | ||||||
Capital Expenditure | -44,953 | -38,855 | -33,960 | -25,858 | -22,601 |
As of September 24, 2026, Trial Holdings published financial results for the second quarter of 2026, having revenues of 360.54B yen and net loss of -2.4B yen, representing a sharp 76.3% rise in revenues, with a shift from a profit per share in the same quarter last year to a loss per share in the current quarter. A positive sign is that for the 12th consecutive quarter, the company has demonstrated an increase in its income line compared to the corresponding quarter of the previous year, indicating the company's stability and potential for growth in the future.
Additionally, the EBITDA margin experienced a slight decrease from 5.43% in the corresponding quarter last year to 4.81%. The dividend yield for this stock is approximately 0.5%, and it trades at 129.6x times current year's earnings, which is higher than the sector average (P/E 10.8x).